United States Ubiquitin Enzymes Market Report 2017

January 2017 | 119 pages | ID: U291B0FE23AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ubiquitin Enzymes

Revenue, means the sales value of Ubiquitin Enzymes

This report studies sales (consumption) of Ubiquitin Enzymes in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• 3SBio
• 5AM Ventures
• Abbiotec
• Abcam
• AcelRx Pharmaceuticals
• Aegera Therapeutics
• Aeneas Ventures
• Agilis Biotherapeutics
• Aileron Therapeutics
• Aju IB Investment
• Alexion Pharmaceuticals
• Almac Discovery
• Amgen
• Angelman Syndrome Foundation
• Apeiron Biologics
• Boston Biochem
• Boston University Technology Development Fund
• BostonBiochem
• BPS Biosciences
• Business Development Bank of Canada
• Business Development Corporation (BDC) Capital
• C4 Therapeutics
• Calculus Capital
• Canaan Partners
• Cancer Research Technology
• Captor Therapeutics
• Carmot Therapeutics
• Cayman Chemicals
• Celgene Corporation
• Cell Signaling Technology

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
• E3 ENZYMES AS THERAPEUTIC TARGETS
• DUB ENZYMES AS THERAPEUTIC TARGETS
• ASSOCIATED DRUG CLASSES

Split by applications, this report focuses on sales, market share and growth rate of Ubiquitin Enzymes in each application, can be divided into

• Cancer
• Biological Engineering
• Others

Contents

United States Ubiquitin Enzymes Market Report 2017

1 UBIQUITIN ENZYMES OVERVIEW

1.1 Product Overview and Scope of Ubiquitin Enzymes
1.2 Classification of Ubiquitin Enzymes
  1.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
  1.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  1.2.3 DUB ENZYMES AS THERAPEUTIC TARGETS
  1.2.4 ASSOCIATED DRUG CLASSES
1.3 Application of Ubiquitin Enzymes
  1.3.1 Cancer
  1.3.2 Biological Engineering
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Ubiquitin Enzymes (2012-2022)
  1.4.1 United States Ubiquitin Enzymes Sales and Growth Rate (2012-2022)
  1.4.2 United States Ubiquitin Enzymes Revenue and Growth Rate (2012-2022)

2 UNITED STATES UBIQUITIN ENZYMES COMPETITION BY MANUFACTURERS

2.1 United States Ubiquitin Enzymes Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ubiquitin Enzymes Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ubiquitin Enzymes Average Price by Manufactures (2015 and 2016)
2.4 Ubiquitin Enzymes Market Competitive Situation and Trends
  2.4.1 Ubiquitin Enzymes Market Concentration Rate
  2.4.2 Ubiquitin Enzymes Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES UBIQUITIN ENZYMES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Ubiquitin Enzymes Sales and Market Share by States (2012-2017)
3.2 United States Ubiquitin Enzymes Revenue and Market Share by States (2012-2017)
3.3 United States Ubiquitin Enzymes Price by States (2012-2017)

4 UNITED STATES UBIQUITIN ENZYMES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Ubiquitin Enzymes Sales and Market Share by Type (2012-2017)
4.2 United States Ubiquitin Enzymes Revenue and Market Share by Type (2012-2017)
4.3 United States Ubiquitin Enzymes Price by Type (2012-2017)
4.4 United States Ubiquitin Enzymes Sales Growth Rate by Type (2012-2017)

5 UNITED STATES UBIQUITIN ENZYMES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ubiquitin Enzymes Sales and Market Share by Application (2012-2017)
5.2 United States Ubiquitin Enzymes Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES UBIQUITIN ENZYMES MANUFACTURERS PROFILES/ANALYSIS

6.1 3SBio
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.1.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.1.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.1.3 3SBio Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 5AM Ventures
  6.2.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.2.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.2.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.2.3 5AM Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abbiotec
  6.3.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.3.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.3.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.3.3 Abbiotec Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abcam
  6.4.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.4.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.4.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.4.3 Abcam Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AcelRx Pharmaceuticals
  6.5.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.5.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.5.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.5.3 AcelRx Pharmaceuticals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Aegera Therapeutics
  6.6.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.6.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.6.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.6.3 Aegera Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Aeneas Ventures
  6.7.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.7.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.7.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.7.3 Aeneas Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Agilis Biotherapeutics
  6.8.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.8.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.8.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.8.3 Agilis Biotherapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aileron Therapeutics
  6.9.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.9.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.9.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.9.3 Aileron Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Aju IB Investment
  6.10.2 Ubiquitin Enzymes Product Type, Application and Specification
    6.10.2.1 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    6.10.2.2 E3 ENZYMES AS THERAPEUTIC TARGETS
  6.10.3 Aju IB Investment Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Alexion Pharmaceuticals
6.12 Almac Discovery
6.13 Amgen
6.14 Angelman Syndrome Foundation
6.15 Apeiron Biologics
6.16 Boston Biochem
6.17 Boston University Technology Development Fund
6.18 BostonBiochem
6.19 BPS Biosciences
6.20 Business Development Bank of Canada
6.21 Business Development Corporation (BDC) Capital
6.22 C4 Therapeutics
6.23 Calculus Capital
6.24 Canaan Partners
6.25 Cancer Research Technology
6.26 Captor Therapeutics
6.27 Carmot Therapeutics
6.28 Cayman Chemicals
6.29 Celgene Corporation
6.30 Cell Signaling Technology

7 UBIQUITIN ENZYMES MANUFACTURING COST ANALYSIS

7.1 Ubiquitin Enzymes Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ubiquitin Enzymes

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ubiquitin Enzymes Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ubiquitin Enzymes Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES UBIQUITIN ENZYMES MARKET FORECAST (2017-2022)

11.1 United States Ubiquitin Enzymes Sales, Revenue Forecast (2017-2022)
11.2 United States Ubiquitin Enzymes Sales Forecast by Type (2017-2022)
11.3 United States Ubiquitin Enzymes Sales Forecast by Application (2017-2022)
11.4 Ubiquitin Enzymes Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ubiquitin Enzymes
Table Classification of Ubiquitin Enzymes
Figure United States Sales Market Share of Ubiquitin Enzymes by Type in 2015
Figure E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS Picture
Figure E3 ENZYMES AS THERAPEUTIC TARGETS Picture
Figure DUB ENZYMES AS THERAPEUTIC TARGETS Picture
Figure ASSOCIATED DRUG CLASSES Picture
Table Application of Ubiquitin Enzymes
Figure United States Sales Market Share of Ubiquitin Enzymes by Application in 2015
Figure Cancer Examples
Figure Biological Engineering Examples
Figure Others Examples
Figure United States Ubiquitin Enzymes Sales and Growth Rate (2012-2022)
Figure United States Ubiquitin Enzymes Revenue and Growth Rate (2012-2022)
Table United States Ubiquitin Enzymes Sales of Key Manufacturers (2015 and 2016)
Table United States Ubiquitin Enzymes Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ubiquitin Enzymes Sales Share by Manufacturers
Figure 2016 Ubiquitin Enzymes Sales Share by Manufacturers
Table United States Ubiquitin Enzymes Revenue by Manufacturers (2015 and 2016)
Table United States Ubiquitin Enzymes Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ubiquitin Enzymes Revenue Share by Manufacturers
Table 2016 United States Ubiquitin Enzymes Revenue Share by Manufacturers
Table United States Market Ubiquitin Enzymes Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ubiquitin Enzymes Average Price of Key Manufacturers in 2015
Figure Ubiquitin Enzymes Market Share of Top 3 Manufacturers
Figure Ubiquitin Enzymes Market Share of Top 5 Manufacturers
Table United States Ubiquitin Enzymes Sales by States (2012-2017)
Table United States Ubiquitin Enzymes Sales Share by States (2012-2017)
Figure United States Ubiquitin Enzymes Sales Market Share by States in 2015
Table United States Ubiquitin Enzymes Revenue and Market Share by States (2012-2017)
Table United States Ubiquitin Enzymes Revenue Share by States (2012-2017)
Figure Revenue Market Share of Ubiquitin Enzymes by States (2012-2017)
Table United States Ubiquitin Enzymes Price by States (2012-2017)
Table United States Ubiquitin Enzymes Sales by Type (2012-2017)
Table United States Ubiquitin Enzymes Sales Share by Type (2012-2017)
Figure United States Ubiquitin Enzymes Sales Market Share by Type in 2015
Table United States Ubiquitin Enzymes Revenue and Market Share by Type (2012-2017)
Table United States Ubiquitin Enzymes Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ubiquitin Enzymes by Type (2012-2017)
Table United States Ubiquitin Enzymes Price by Type (2012-2017)
Figure United States Ubiquitin Enzymes Sales Growth Rate by Type (2012-2017)
Table United States Ubiquitin Enzymes Sales by Application (2012-2017)
Table United States Ubiquitin Enzymes Sales Market Share by Application (2012-2017)
Figure United States Ubiquitin Enzymes Sales Market Share by Application in 2015
Table United States Ubiquitin Enzymes Sales Growth Rate by Application (2012-2017)
Figure United States Ubiquitin Enzymes Sales Growth Rate by Application (2012-2017)
Table 3SBio Basic Information List
Table 3SBio Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure 3SBio Ubiquitin Enzymes Sales Market Share (2012-2017)
Table 5AM Ventures Basic Information List
Table 5AM Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table 5AM Ventures Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Abbiotec Basic Information List
Table Abbiotec Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbiotec Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Abcam Basic Information List
Table Abcam Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abcam Ubiquitin Enzymes Sales Market Share (2012-2017)
Table AcelRx Pharmaceuticals Basic Information List
Table AcelRx Pharmaceuticals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table AcelRx Pharmaceuticals Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Aegera Therapeutics Basic Information List
Table Aegera Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aegera Therapeutics Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Aeneas Ventures Basic Information List
Table Aeneas Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aeneas Ventures Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Agilis Biotherapeutics Basic Information List
Table Agilis Biotherapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Agilis Biotherapeutics Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Aileron Therapeutics Basic Information List
Table Aileron Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aileron Therapeutics Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Aju IB Investment Basic Information List
Table Aju IB Investment Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aju IB Investment Ubiquitin Enzymes Sales Market Share (2012-2017)
Table Alexion Pharmaceuticals Basic Information List
Table Almac Discovery Basic Information List
Table Amgen Basic Information List
Table Angelman Syndrome Foundation Basic Information List
Table Apeiron Biologics Basic Information List
Table Boston Biochem Basic Information List
Table Boston University Technology Development Fund Basic Information List
Table BostonBiochem Basic Information List
Table BPS Biosciences Basic Information List
Table Business Development Bank of Canada Basic Information List
Table Business Development Corporation (BDC) Capital Basic Information List
Table C4 Therapeutics Basic Information List
Table Calculus Capital Basic Information List
Table Canaan Partners Basic Information List
Table Cancer Research Technology Basic Information List
Table Captor Therapeutics Basic Information List
Table Carmot Therapeutics Basic Information List
Table Cayman Chemicals Basic Information List
Table Celgene Corporation Basic Information List
Table Cell Signaling Technology Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ubiquitin Enzymes
Figure Manufacturing Process Analysis of Ubiquitin Enzymes
Figure Ubiquitin Enzymes Industrial Chain Analysis
Table Raw Materials Sources of Ubiquitin Enzymes Major Manufacturers in 2015
Table Major Buyers of Ubiquitin Enzymes
Table Distributors/Traders List
Figure United States Ubiquitin Enzymes Production and Growth Rate Forecast (2017-2022)
Figure United States Ubiquitin Enzymes Revenue and Growth Rate Forecast (2017-2022)
Table United States Ubiquitin Enzymes Production Forecast by Type (2017-2022)
Table United States Ubiquitin Enzymes Consumption Forecast by Application (2017-2022)
Table United States Ubiquitin Enzymes Sales Forecast by States (2017-2022)
Table United States Ubiquitin Enzymes Sales Share Forecast by States (2017-2022)